Johnson & Johnson Receives CE Marking For ACUVUE OASYS MAX 2-Week, New Reusable Contact Lens Featuring Proprietary MAX Technologies To Deliver Lasting Comfort And Clear Vision, Even At Day 14

• New 2-week reusable contact lens brings advanced ACUVUE OASYS MAX technologies to deliver superior comfort and visual clarity to patients, even at day 14
• Expands the ACUVUE OASYS MAX portfolio with an advanced option for reusable contact lens wearers
• Designed to meet the growing demand for lasting comfort and clear vision in today’s screen-intensive world *

Johnson & Johnson (NYSE:JNJ) today announced that it has received CE Marking for ACUVUE OASYS MAX 2-Week,*** a new reusable contact lens featuring proprietary MAX technologies designed to deliver superior comfort and visual clarity, even at day 14. The lens will be rolled out in select European countries later this year with wider market rollout in 2027.

Globally, 140 million people wear contact lenses, with one in two choosing a reusable lens, and comfort remains their leading priority. With the continued rise in everyday use of digital devices and exposure to blue-violet light, more demands are being placed on patients’ eyes, often leading to reduced visual clarity and symptoms of dryness. ACUVUE OASYS MAX 2-Week brings Johnson & Johnson’s advanced MAX contact lens technologies to reusable contact lens wearers, helping address their evolving vision, comfort, and digital lifestyle needs.